CSVAX | DODFX | CSVAX / DODFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 23 years | - |
Gain YTD | 7.407 | 8.238 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 2500 | 80% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 551M | 50.3B | 1% |
Annual Yield % from dividends | 2.21 | 2.22 | 100% |
Returns for 1 year | 15.42 | 13.94 | 111% |
Returns for 3 years | 0.94 | 13.44 | 7% |
Returns for 5 years | 21.79 | 44.35 | 49% |
Returns for 10 years | 8.31 | 26.26 | 32% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NALFX | 67.89 | 0.77 | +1.15% |
New Alternatives A | |||
ARYDX | 13.79 | 0.02 | +0.15% |
American Century Global Real Estate R6 | |||
RECRX | 13.04 | N/A | N/A |
RBC Emerging Markets Ex-China Equity R6 | |||
JLCAX | 19.89 | -0.04 | -0.20% |
JPMorgan US Large Cap Core Plus A | |||
PAULX | 41.94 | -0.16 | -0.38% |
T. Rowe Price US Large-Cap Core Adv |